New
HealthMore in Health→
Alzheimer’s patients seeking lecanemab often skip brain-health basics
Key Takeaways
- Researchers studied 150 patients seeking anti-amyloid therapy and 117 who were not.
- Fewer than 3% of patients followed all 15 brain-health recommendations assessed.
- Patients pursuing lecanemab did not show significantly better adherence than the comparison group.
DE
DT Editorial Team··via medicalxpress.com